Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institutionM. Azoulay, Bassam Abdulkarim, Fabiano Santos et al.|Journal of Neuro-Oncology|2017Cited by 83
Prognostic factors for progression in atypical meningiomaShakir I. Shakir, Marie‐Christine Guiot, Bassam Abdulkarim et al.|Journal of neurosurgery|2018Cited by 65
A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With GlioblastomaGeorge Shenouda, Bassam Abdulkarim, Luís Souhami et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 58
Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to TemozolomideZeinab Sharifi, Siham Sabri, Janusz Rak et al.|Clinical Cancer Research|2019Cited by 58
Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institutionM. Azoulay, Bassam Abdulkarim, Mariia Patyka et al.|Radiation Oncology|2015Cited by 21